Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Magnachip Semiconductor
MX
$137M
| $956K | ﹤0.01% |
237,900
+44,546
| +23% | +$190K |
|
2527
Babcock & Wilcox
BW
$1.54B
| $956K | ﹤0.01% |
582,734
-166,004
| -22% | -$351K |
|
2528
Sky Harbour Group
SKYH
$359M
| $948K | ﹤0.01% |
79,500
+64,700
| +437% | +$756K |
|
2529
Palmer Square Capital BDC
PSBD
$318M
| $942K | ﹤0.01% |
62,000
-4,400
| -7% | -$70.1K |
|
2530
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$197M
| $942K | ﹤0.01% |
23,700
-104,400
| -81% | -$3.62M |
|
2531
Insteel Industries
IIIN
$634M
| $937K | ﹤0.01% |
34,700
-48,440
| -58% | -$1.41M |
|
|
OPOF
2532
DELISTED
Old Point Financial
OPOF
| $936K | ﹤0.01% |
35,929
+5,500
| +18% | +$118K |
|
2533
Joby Aviation
JOBY
$7.9B
| $936K | ﹤0.01% |
+115,131
| New | +$763K |
|
2534
iShares MSCI Singapore ETF
EWS
$1.16B
| $933K | ﹤0.01% |
42,700
+5,700
| +15% | +$127K |
|
2535
Titan Machinery
TITN
$427M
| $931K | ﹤0.01% |
65,899
-120,401
| -65% | -$1.74M |
|
2536
Flanigan's Enterprises
BDL
$87M
| $929K | ﹤0.01% |
36,793
-2,100
| -5% | -$53.1K |
|
2537
Stereotaxis
STXS
$137M
| $926K | ﹤0.01% |
406,200
+44,000
| +12% | +$92K |
|
2538
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
| $925K | ﹤0.01% |
13,800
-49,700
| -78% | -$3.37M |
|
2539
Journey Medical
DERM
$181M
| $923K | ﹤0.01% |
236,000
-32,200
| -12% | -$176K |
|
2540
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.98B
| $921K | ﹤0.01% |
10,600
+5,500
| +108% | +$495K |
|
2541
SEACOR Marine Holdings
SMHI
$265M
| $921K | ﹤0.01% |
140,400
-45,800
| -25% | -$340K |
|
2542
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.6B
| $920K | ﹤0.01% |
+16,597
| New | +$974K |
|
2543
Village Farms International
VFF
$311M
| $918K | ﹤0.01% |
1,190,633
+80,567
| +7% | +$67.3K |
|
2544
Olema Pharmaceuticals
OLMA
$921M
| $917K | ﹤0.01% |
157,300
+127,900
| +435% | +$1.28M |
|
2545
Research Solutions
RSSS
$77.3M
| $917K | ﹤0.01% |
220,900
+97,154
| +79% | +$307K |
|
|
STRR
2546
Star Equity Holdings
STRR
$34.7M
| $915K | ﹤0.01% |
70,122
-4,003
| -5% | -$59.1K |
|
2547
Ampco-Pittsburgh
AP
$196M
| $913K | ﹤0.01% |
436,619
-16,800
| -4% | -$31.9K |
|
2548
First Bank
FRBA
$471M
| $911K | ﹤0.01% |
64,756
-1,595
| -2% | -$23.4K |
|
|
CTLP
2549
DELISTED
Cantaloupe
CTLP
| $906K | ﹤0.01% |
95,300
+15,100
| +19% | +$137K |
|
2550
Gevo
GEVO
$413M
| $904K | ﹤0.01% |
+432,330
| New | +$819K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.